JAMA Forum: The Risks and Benefits of Expedited Drug Reviews
news@JAMA,
The US Food and Drug Administration (FDA) oversees several programs that expedite approval of certain drugs that treat serious…
The US Food and Drug Administration (FDA) oversees several programs that expedite approval of certain drugs that treat serious…
The promising pipeline of drugs in development for rare diseases does not fully deliver, with only 15% of products with an…